Brigitte Boeser‐Nunnink

Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

Evelien M. Bunnik, Zelda Euler, Matthijs R. A. Welkers et al. · Nature Medicine · 2010 · 125 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies

Marit J. van Gils, Evelien M. Bunnik, Brigitte Boeser‐Nunnink et al. · Journal of Virology · 2011 · 94 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection

Daniëlle van Manen, Neeltje A. Kootstra, Brigitte Boeser‐Nunnink et al. · AIDS · 2008 · 90 citations

Life Sciences, Genetics, Molecular Genetics +16

GB Virus C Coinfection and HIV‐1 Disease Progression: The Amsterdam Cohort Study

Akke K. van der Bij, Nico Kloosterboer, Maria Prins et al. · The Journal of Infectious Diseases · 2005 · 86 citations · Full text

Public Health, Immunology, Infectious Diseases +10

Decreasing Sensitivity to RANTES (Regulated on Activation, Normally T Cell–Expressed and –Secreted) Neutralization of CC Chemokine Receptor 5–Using, Non–Syncytium‐Inducing Virus Variants in the Course of Human Immunodeficiency Virus Type 1 Infection

David Kwa, Brigitte Boeser‐Nunnink, Jos Dekker et al. · The Journal of Infectious Diseases · 2003 · 84 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12